-
Artefan Tablets 20/120 mg 24's
KSh 55.00
-
Alerid Syrup 30ml
KSh 90.00
-
DTS-Z Kit (ORS +Zinc Tab)
KSh 90.00
Glypy Met 50/500mg Tablets 30’s
KSh 599.00
Glypy Met 50/500mg Tablets combine Vidagliptin (50mg) and Metformin Hydrochloride (500mg) to effectively manage type 2 diabetes. This combination helps regulate blood sugar levels, reducing the risk of complications and providing better control for patients who require more than lifestyle changes or single-drug treatment.
Anti-Diabetics
Suggested Use
- Glypy Met 50/500mg is indicated for adults with type 2 diabetes mellitus to improve blood sugar control alongside diet and exercise.
- This combination is typically prescribed when previous treatments, such as Metformin alone, do not provide adequate control.
- It may also be used as part of dual therapy in combination with other antidiabetic medications as per a physician’s advice.
The exact dosage should always be determined by a healthcare provider based on the patient’s individual needs and blood glucose levels.
Warning
- Glypy Met 50/500mg is not suitable for patients with type 1 diabetes or diabetic ketoacidosis.
- When combined with other antidiabetic drugs, such as insulin or sulfonylureas, there may be an increased risk of low blood sugar (hypoglycemia).
- Use with caution in patients with renal or hepatic impairment, as this can affect drug clearance. Regular monitoring of renal function is advised.
- Metformin can cause lactic acidosis, a rare but serious metabolic complication. Patients should seek immediate medical attention if they experience symptoms like muscle pain, trouble breathing, stomach pain, or unusual tiredness.
- Limit alcohol intake, as it can increase the risk of lactic acidosis and affect blood sugar control.
- Pregnancy and Breastfeeding: Not recommended unless clearly needed and prescribed by a healthcare provider.
- Common Side Effects: Gastrointestinal issues (nausea, vomiting, diarrhoea), Headache and dizziness, Possible metallic taste in the mouth
